Inozyme Pharma stock hits 52-week low at $1.32 amid market challenges
Inozyme Pharma Inc. (INZY) stock has tumbled to a 52-week low, reaching a price level of just $1.32. This significant downturn reflects a challenging period for the biopharmaceutical company, which ...
India approves $1.32 billion revival plan for debt-laden RINL, minister says
India's federal cabinet has approved a financial plan of 114.40 billion rupees ($1.32 billion) to revive debt-laden steel ...
Fathom Holdings Stock Hits 52-Week Low at $1.32 Amid Market Challenges
Fathom Holdings Inc. (FTHM), a real estate brokerage company with annual revenue of $317.51 million, has seen its stock price touch a 52-week low, reaching a price level of $1.32 USD. According to ...